Vladimír Džavík

Vladimír Džavík

Auto-generated profile, based on publicly available information

Vladimír Džavík

Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
VDVladimír Džavík
Vladimír Džavík
ACAntonio Colombo
Antonio Colombo

1 February 2014 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
MKMark A. Kotowycz
Mark A. Kotowycz
KJK. Wayne Johnston
K. Wayne Johnston
JIJoan Ivanov
Joan Ivanov
NANadia Asif
Nadia Asif
AAAbdulrahman M. Almoghairi
Abdulrahman M. Almoghairi
VDVladimír Džavík
Vladimír Džavík

1 January 2015 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
WCWilliam Chan
William Chan
JIJoan Ivanov
Joan Ivanov
DKDennis Ko
Dennis Ko
SFStephen E. Fremes
Stephen E. Fremes
VRVivek Rao
Vivek Rao
VDVladimír Džavík
Vladimír Džavík
Background—: There is a paucity of data on the comparative effectiveness of percutaneous coronary intervention using contemporary drug-eluting stent (DES) compared with coronary artery bypass graft (CABG) surgery in patients with chronic kidney disease. Methods and Results—: A population-based study was performed using the Cardiac Care Network, a provincial registry of all patients undergoing cardiac catheterization in Ontario, to evaluate patients treated with either percutaneous coronary intervention using DES or CABG between October 1, 2008, and September 30, 2011. Chronic kidney disease was defined as creatinine clearance <60 mL/min. A total of 1786 propensity-matched patients from 4006 patients with chronic kidney disease undergoing index revascularization for multivessel disease with either DES or isolated CABG (n=893 each group) were analyzed. Baseline and procedural characteristics between percutaneous coronary intervention and CABG groups were well-balanced, including urgent revascularization priority, diabetes mellitus, left ventricular function, and 3-vessel disease. The 1-, 2-, and 3-year Kaplan–Meier survival analyses in propensity-matched patients favored CABG (93.2% versus 89.3%; 86.6% versus 80.3%; 80.8% versus 71.5%, respectively; P <0.001). The CABG cohort had greater 1-, 2-, and 3-year freedom from major adverse cardiac and cerebrovascular events (89.4% versus 71.2%; 81.9% versus 60.5%; 75.2% versus 51.8%, respectively; P <0.001). Cox regression analysis identified DES use to be associated with greater hazard for late mortality (hazard ratio, 1.58; 95% confidence interval, 1.32–1.90) and major adverse cardiac and cerebrovascular events (2.62; 2.28–3.01; all P <0.001). Conclusions—: In this large provincial registry, CABG was associated with improved early and late clinical outcomes when compared with percutaneous coronary intervention using DES in patients with chronic kidney disease undergoing index revascularization.

17 April 2012 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MSMatthew Sibbald
Matthew Sibbald
VDVladimír Džavík
Vladimír Džavík

31 August 2010 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
OBOlivier F. Bertrand
Olivier F. Bertrand
PPPaul Poirier
Paul Poirier
JRJosep Rodés-Cabau
Josep Rodés-Cabau
SRStéphane Rinfret
Stéphane Rinfret
LTLawrence M. Title
Lawrence M. Title
JDJean-Pierre Després
Jean-Pierre Després

1 February 2013 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
KHKay W. Ho
Kay W. Ho
JIJoan Ivanov
Joan Ivanov
XFXavier Freixa
Xavier Freixa
COChristopher B. Overgaard
Christopher B. Overgaard
MOMark D. Osten
Mark D. Osten
VDVladimír Džavík
Vladimír Džavík